Duplex DNA recognition by oligonucleotide-directed triple helix formation is being explored as a highly specific approach to artificial gene repression. We have identified two potential triplex target sequences in the promoter of the human bcl-2 gene, whose product inhibits apoptosis. Oligonucleotides designed to bind these target sequences were tested for their binding affinities and specificities under pseudophysiological conditions. Electrophoretic mobility shift and dimethyl sulfate footprinting assays demonstrated that an oligonucleotide designed for simultaneous recognition of homopurine domains on alternate duplex DNA strands had the highest affinity of any oligonucleotide tested. Modifications to render this oligonucleotide nuclease-resistant did not reduce its binding affinity or specificity. In additional studies under various pH conditions, pyrimidine motif complexes at these target sequences were found to be stable at pH 8.0, despite the presumed requirement for protonation of oligonucleotide cytidines. In contrast, purine motif complexes, typically considered to be pH independent, were highly destabilized at decreasing pH values. These results indicate that a natural sequence in the human bcl-2 promoter can form a stable triplex with a synthetic oligonucleotide under pseudo-physiological conditions, and suggest that triple helix formation might provide an approach to the artificial repression of bcl-2 transcription.
INTRODUCTION
Oligonucleotide-directed triple helix formation is a highly specific strategy for designing potential artificial gene repressors (1) (2) (3) (4) (5) . In vitro experiments provide evidence that triplexes can block DNA binding proteins (6) (7) (8) and inhibit transcription initiation (2, (9) (10) (11) (12) (13) . Recognition of homopurine/homopyrimidine sequences involves hydrogen bonds between oligonucleotide bases and purine bases in the major groove of duplex DNA. Triple helix formation occurs in either of two distinct patterns, termed the pyrimidine (Pyr) motif and purine (Pur) motif (4) . In the pyrimidine motif, oligonucleotides bind parallel to the purine strand of the duplex by Hoogsteen hydrogen bonding to form T·A·T and C+·G·C base triplets (1) . In the purine motif, oligonucleotides bind antiparallel to the purine strand of the duplex by reverse Hoogsteen hydrogen bonding to form A·A·T (or T·A·T) and G·G·C base triplets (14) . We are interested in the possibility that triple helix formation might be used to artificially regulate the expression of disease-related genes.
The product of the bcl-2 proto-oncogene acts as a negative regulator of programmed cell death (apoptosis; [15] [16] [17] . Apoptosis not only provides a termination option for cells that are dangerously damaged, but also plays a key role in normal T and B cell development (18) (19) (20) . In some tissues, the propensity toward apoptosis appears to be regulated by the ratio of bcl-2 and bax proteins. Increases in bax concentrations counter the apoptotic suppression by bcl-2 (21) . One of the most common cytogenetic abnormalities in non-Hodgkin B cell lymphomas is the translocation t(14;18)(q32;q21). This translocation places the bcl-2 gene at 14q21 under the control of the immunoglobulin heavy-chain gene enhancer, resulting in bcl-2 overexpression (22, 23) . Studies of transgenic mice overexpressing bcl-2 show an increase in both B and T cell survival, leading to lymphomas derived from both cell types (22) . In contrast, bcl-2 -/-knockout mice undergo profound apoptotic deletion of B and T cells shortly after birth (24) .
Therapeutic techniques such as radiation and many chemical agents act by inducing apoptosis. This observation suggests that approaches to reducing the damage threshold required for induction of cell death by an apoptotic signal may sensitize tumor cells to chemotherapeutic agents. One such approach might be to artificially reduce bcl-2 levels in cells by repression of bcl-2 transcription via triple helix formation targeted to the bcl-2 promoter region. The human bcl-2 gene is transcribed from two promoters (P1 and P2; Fig. 1 ). The major promoter (P1) lacks a TATA box, is GC rich, contains seven consensus Sp1 binding sites, and displays multiple transcription initiation sites (23) . We have identified two homopurine sequences just upstream of this major bcl-2 promoter that might serve as triplex target sites.
We wished to design oligonucleotides that might bind the bcl-2 target sequences with high specificity and affinity under physiological conditions. Electrophoretic mobility shift titrations were performed to estimate oligonucleotide affinities, while dimethyl sulfate footprinting assays were used to analyze oligonucleotide recognition and induced changes in the structure of the duplex target upon triplex formation. We report that under pseudophysiological conditions, an oligonucleotide designed for adjacent purine and pyrimidine motif recognition binds homopurine domains on alternate duplex DNA strands with high affinity. This result provides an example of a naturally-occurring target sequence for which alternate strand triple helix formation clearly increases binding affinity relative to recognition of a single homopurine domain. Modifications to render this high-affinity oligonucleotide nuclease-resistant did not reduce its binding affinity. While many pyrimidine motif oligonucleotides require an acidic pH to protonate cytidine residues for tight binding to duplex DNA, the pyrimidine motif complexes in this study were remarkably stable at pH 8.0. In contrast, the stabilities of purine motif complexes, often considered to be pH independent, were in this study highly reduced at decreasing pH values. Together, these results identify oligonucleotides that bind tightly to the human bcl-2 promoter under pseudo-physiological conditions. These results suggest a possible strategy for artificial repression of bcl-2 transcription.
MATERIALS AND METHODS

Oligonucleotides
Oligonucleotide sequences are shown in Figure 1B . Oligonucleotides were synthesized by phosphoramidite chemistry on an ABI Model 380B DNA synthesizer, purified by denaturing polyacrylamide gel electrophoresis, eluted from gel slices, and desalted by Sep-Pak C 18 cartridge chromatography (Waters). Oligonucleotides were quantitated by absorbance at 260 nm using molar extinction coefficients (M -1 cm -1) of 15 400 (dA), 11 700 (dG), 7300 (dC), 5700 (dMe5C) and 8800 (dT), assuming no hypochromicity. Oligonucleotides comprising the target duplexes were annealed as follows: 500 pmol each of oligonucleotides A and B for the Pur1 duplex or oligonucleotides C and D for the Pur2 duplex were mixed with 2 µl 5 M NaCl and brought to a total volume of 42 µl with H 2 O. This annealing reaction mixture was incubated at 75_C for 12 min and then gradually cooled to 25_C. Thirty pmol of the resulting oligonucleotide duplexes were radiolabeled using the Klenow fragment of DNA polymerase I and [α-32 P]dATP in the presence of 0.1 mM dGTP, dTTP and dCTP. The resulting labeled duplex oligonucleotides were purified by precipitation from ethanol in the presence of ammonium acetate, and resuspended in H 2 O.
Electrophoretic DNA mobility shift assays
Four different binding buffers were employed in these studies: pH 5.0 (100 mM NaOAc, pH 5.0, 5 mM NaCl, 10 . Electrophoresis was performed with recirculation at 4_C overnight (9 V/cm). The resulting gel was imaged and quantified by storage phosphor technology using a Molecular Dynamics PhosphorImager.
Analysis of DNA gel mobility shift titrations
The apparent fraction, θ of target duplex bound by oligonucleotide was calculated for each gel lane using the definition: θ = S triplex / (S triplex + S duplex ) 1 where S triplex and S duplex represent the storage phosphor signal for triplex and duplex complexes respectively. Values of the apparent triplex dissociation constant, K d , were obtained by least squares fitting of the data to the binding isotherm:
is the concentration of oligonucleotide, and n is the Hill coefficient (25) .
Dimethyl sulfate footprinting
Pur1 and Pur2 duplexes were each ligated into plasmid pG5E4T that had been cleaved by BamHI and PstI (11) . Clones bearing the desired insertions were confirmed by sequencing. A 356 bp HindIII-SacI restriction fragment from the Pur1-containing plasmid and a 361 bp HindIII-SacI restriction fragment from the Pur2-containing plasmid were then prepared and dephosphorylated with calf intestinal alkaline phosphatase. The Pur1 and Pur2 fragments were uniquely end-labeled on strands B and D respectively, using polynucleotide kinase (see Fig. 1 ). For some experiments, the Pur2 fragment was uniquely end-labeled on strand C using the Klenow fragment of DNA polymerase I (see Fig. 1 ). Labeled fragment (50 000 c.p.m.; ∼0.1 pmol) was incubated with either 1 µl of 10× pH 8.0 binding buffer or 2 µl of 5× nuclear extract buffer (NEB), 1 µl of 1 mg/ml yeast tRNA, 1 µl of 10 µM oligonucleotide, and H 2 O in a final volume of 10 µl. Binding reactions were incubated overnight at 22_C. Dimethyl sulfate [1 µl of a 4% (v/v) aqueous solution] was added to each reaction mixture and allowed to incubate for 30 min at 4_C. Reactions were terminated with 5 µl of stop mix [1.5 M NaOAc, 7% (v/v) β-mercaptoethanol and 100 µg/ml yeast tRNA]. For formic acid treatment, 25 µl of formic acid was allowed to incubate with reaction mixture for 2 min at 22_C, then the reaction was terminated with 180 µl of HZ stop mix (0.3 M NaOAc, 0.1 mM EDTA, 25 µg/ml tRNA). Following ethanol precipitation, 100 µl of 10% piperidine was added, and the samples were incubated for 30 min at 90_C. Piperidine was removed by repeated lyophilization. The DNA was then resuspended in 5 µl of formamide dye mix, heated to 90_C, electrophoresed on an 8% polyacrylamide sequencing gel [19:1 (acrylamide:bisacrylamide)] containing 7.5 M urea in 0.5× TBE buffer (50 mM Tris base, 55 mM boric acid, 1 mM EDTA), and imaged by storage phosphor technology.
RESULTS
Experimental design
Studies of triple helix formation often employ non-physiological conditions such as acidic pH and/or low monovalent cation concentrations. We wished to study triple helix formation under physiological conditions at a natural target sequence. The bcl-2 gene, whose product inhibits apoptosis, contains two potential triplex target sequences just upstream of the predominant promoter, P1 ( Fig. 1A; 26) . One target sequence, termed Pur1, is located 32 bp upstream of the 5′-most major transcription start site (position -1432; Fig. 1A ; 23) and consists of a 25 base purine-rich sequence with three pyrimidine interruptions (Fig. 1B) . The second target sequence, termed Pur2, is located 136 bp upstream of the first major transcription start site and consists of two adjacent homopurine sequences; nine purines on one strand of the duplex directly adjacent to 21 purines on the opposite strand (Fig. 1B) . To facilitate electrophoretic mobility analyses of oligonucleotide binding and to simplify cloning procedures, synthetic duplexes were designed containing the Pur1 and Pur2 sequences (Pur1 duplex and Pur2 duplex respectively; Fig. 1B) .
The purine triple helix motif, most appropriate for guanine-rich target sites, was used to design triplex oligonucleotides to recognize the Pur1 target sequence. Oligonucleotide Pur1-Long was designed to span the entire Pur1 region, with thymidine residues used to cross interrupting pyrimidines in the target (Fig. 1B) . Pur1-Short, which recognizes only 19 bases of the target, was designed to avoid two of the three interrupting pyrimidines of the target sequence (Fig. 1B) .
It has previously been shown that oligonucleotides utilizing consecutive pyrimidine motif and purine motif sequences can simultaneously recognize purine domains on opposite strands of duplex DNA, such as those in the Pur2 target sequence (27) (28) (29) (30) (31) . Target recognition is accomplished by switching triplex motifs, and thus relative strand polarities, as the oligonucleotide crosses between purine domains. The pyrimidine triple helix motif, appropriate for an adenine-rich target site, was used to design oligonucleotide Pur2-Pyr to recognize the 19 base domain of the Pur2 target sequence (Fig. 1B) . Pur2-Pur was designed to recognize the nine base domain of the Pur2 target using the purine motif (Fig. 1B ). These two oligonucleotides were then combined in the design of Pur2-Cross intended to simultaneously recognize both purine domains of the Pur2 target sequence (Fig. 1B) . Using the strategy devised by Beal and Dervan (27) , a cytidine residue was removed from the 5′-pyr motif:pur motif-3′ junction of Pur2-Cross to allow the oligonucleotide to more smoothly cross the major groove between the alternate strand homopurine regions. In addition, all cytidines in oligonucleotides for triple helix formation were modified to 5-methylcytidines to enhance binding at physiological pH (32) . Electrophoretic mobility shift titrations allowed estimation of oligonucleotide binding affinities for bcl-2 duplex targets, while dimethyl sulfate (DMS) footprinting assays were used to study details of oligonucleotide binding. 
Oligonucleotide binding affinities
Equilibrium dissociation constants (K d s) were measured for triplexes in the bcl-2 promoter at various pH values in the range 5.0-8.0. Typically, pyrimidine motif triplexes require cytidine protonation and are stabilized by acidic pH, while the stabilities of purine motif triplexes are thought to be intrinsically pH independent. Figure 2A and B presents examples of binding experiments at pH (Table 1 ).
5.0 and 8.0 respectively, in which labeled Pur1 and Pur2 duplexes were incubated in the presence of increasing oligonucleotide concentrations. Figure 2C and D depicts quantitative results from these experiments. Values of K d were calculated as described in Materials and Methods and are listed in Table 1 . At pH 5.0, purine motif oligonucleotides Pur1-Long and Pur1-Short bound the Pur1 duplex target weakly with K d values >>2.5 × 10 -6 M ( Fig. 2A  and C) . As the pH was increased, oligonucleotide binding in the purine motif increased, with K d values of 2.3 × 10 -7 M and 4.7 × 10 -7 M for Pur1-Long and Pur1-Short respectively, at pH 8.0 (Fig. 2B and D) . This result contradicts the conventional view that triple helix formation in the purine motif is pH independent. However, the basis for suppression of purine motif triplexes at low pH remains unclear. Purine motif oligonucleotide Pur2-Pur did not detectably bind the Pur2 duplex under any pH condition tested, perhaps due to its short length. Both Pur2-Pyr and Pur2-Cross bound the Pur2 duplex with high affinity at pH 5.0 (K d values of 4.4 × 10 -8 M and 5.3 × 10 -8 M respectively; Fig. 2A and C) . Surprisingly, the affinities of these oligonucleotides decreased only slightly at higher pH values (K d values of 1.0 × 10 -7 M and 7.0 × 10 -8 M for Pur2-Pyr and Pur2-Cross respectively at pH 8.0; Fig. 2B and D) . The impressive (Table 1) . ability of these oligonucleotides to bind with high affinity at pH values v8.0 emphasizes the sequence-dependence of triplex affinity. Particularly favorable features of these oligonucleotides may be their thymidine-richness, and absence of the requirement to protonate any consecutive cytidine residues. Binding affinities of Pur2-Pyr and Pur2-Cross were also tested in the presence of a pseudo-physiological pH 7.4 buffer containing 100 mM K + (intracellular [K + ] is thought to be ∼100-200 mM; 33). The observed binding affinity for Pur2-Cross (K d = 6.1 × 10 -8 M) was nearly 2-fold higher than for Pur2-Pyr (K d = 1.1 × 10 -7 M). The Pur2 sequence therefore provides an example of a duplex target where alternate-strand triple helix formation increases oligonucleotide binding affinity under pseudo-physiological conditions, relative to the binding of oligonucleotides to either individual domain.
It is interesting to note that triplexes containing Pur2-Cross have a slightly lower electrophoretic mobility at pH 5.0 than at 8.0 (compare lanes 31-37 of Fig. 2A and B) . This decrease in mobility at low pH may indicate a less compact structure consistent with partial release of the purine motif portion of the complex (31) . This result is in accord with the observation that purine motif triplexes involving Pur1-Long and Pur1-Short are unstable at pH 5.0 ( Fig. 2A) .
If high affinity triplex binding to the promoter region of bcl-2 were considered for the therapeutic enhancement of apoptosis, it would presumably be beneficial to reduce degradation by nucleases. We wished to study whether modifications previously shown to confer nuclease resistance might be tolerated in the bcl-2 triplexes. Because Pur2-Cross had the highest affinity of any oligonucleotide studied under pseudo-physiological conditions, we used its sequence to design nuclease-resistant Pur2-Modified Cross (Fig. 1B) . The purine motif portion of the sequence was modified using a nuclease-resistant phosphorothioate backbone (34) . However, such modifications are not permissive for triplex formation in the pyrimidine motif (35) . Therefore, the pyrimidine motif portion of Pur2-Modified Cross was made nuclease-resistant by substituting 2′-O-methylthymidine for all thymidines (36) . Stabilities of triplexes involving Pur2-Cross versus Pur2-Modified Cross were determined by incubation of the labeled Pur2 duplex with increasing oligonucleotide concentrations at pH 8.0 (Fig. 3A and B) . The K d value of Pur2-Modified Cross (9.9 × 10 -8 M) was not substantially lower than that of Pur2-Cross (7.0 × 10 -8 M).
Details of oligonucleotide specificity and duplex structure
To verify specificity and monitor any changes in target structure upon oligonucleotide binding to the Pur1 and Pur2 duplexes, a DMS footprinting analysis was performed. Protection of guanine N7 from DMS modification is conferred by triple helix formation. After cloning into plasmids, targeted guanines in the Pur1 sequence were specifically, (though weakly) protected by 1 µM of both Pur1-Long and Pur1-Short in pH 8.0 binding buffer (Fig. 4A,  lanes 3 and 4 respectively) . Although this weak footprint indicates a relatively low binding affinity, the high level of background cleavage of this sequence (Fig. 4A, lane 1) should also be noted. The slight hypermethylation of guanines just 3′ of the Pur1-Short binding domain is a phenomenon often seen at sequences adjacent to triplex binding sites and may reflect structural changes in the duplex at the duplex-triplex junction.
In contrast with results at the Pur1 site, guanines within the 21 base homopurine domain on the bottom strand of the Pur2 duplex are strongly protected by Pur2-Pyr, Pur2-Cross and Pur2-Modified Cross under pseudo-physiological conditions (Fig. 4A, lanes 7, 8  and 9 ). Again, significant hypermethylation of the 3′-most guanine of the target sequence is observed in the presence of Pur2-Pyr. Hypermethylation of this guanine is increased further when the target sequence is bound by Pur2-Cross and Pur2-Modified Cross (Fig. 4B) . Note that in an attempt to optimize traversal of the major groove to the alternate strand, these oligonucleotides have been designed with deletion of the cytidine residue that would normally bind this 3′ guanine. Some characteristic of the oligonucleotide transition between alternate strands may increase the perturbation of the duplex structure at this sequence.
As evidence of the simultaneous recognition of alternate DNA strands, it is noteworthy that guanines within the nine base homopurine domain on the top strand of the Pur2 duplex are also strongly protected by Pur2-Cross and Pur2-Modified Cross under pseudo-physiological conditions (Fig. 4A, lanes 14 and  15) . The 3′-most guanine in this domain is also hypermethylated in the presence of Pur2-Cross and Pur2-Modified Cross, most likely due to duplex structural changes at this junction (Fig. 4B) . Methylation can be detected at the 3′ intervening adenine within the target sequence, and this adenine remains unprotected in the presence of either Pur2-Cross or Pur2-Modified Cross. As expected, protection of this domain is not observed in the presence of Pur2-Pyr, which binds only to the alternate strand (Fig. 4A, lane   13 ). However, this oligonucleotide does induce hypermethylation of two guanines within the homopurine region of this strand, again suggesting structural changes induced by triplex formation (Fig. 4B) . These data confirm oligonucleotide specificities and provide strong evidence for the ability of Pur2-Cross and Pur2-Modified Cross to simultaneously bind to alternate DNA strands.
DISCUSSION
We have used the purine and pyrimidine triple helix motifs to design several oligonucleotides to recognize two target sequences in the bcl-2 P1 promoter. At physiological pH, oligonucleotides Pur2-Pyr and Pur2-Cross bound the Pur2 target sequence with K d values near 1 × 10 -7 M, affinities ∼10-fold higher than observed for oligonucleotides Pur1-Long and Pur1-Short binding to the Pur1 target sequence. Pur2-Cross, designed to bind alternate strand homopurine domains, had the highest affinity of all oligonucleotides tested under pseudo-physiological conditions (K d = 6.1 × 10 -8 M).
In the course of binding studies under various pH conditions, we were surprised that purine motif oligonucleotides Pur1-Long and Pur1-Short bound the Pur1 duplex very weakly at low pH. Although there is no intrinsic pH requirement for reverse Hoogsteen hydrogen bonding in the purine motif, this study clearly demonstrates a strong pH dependence for triplexes at this sequence. Triplexes involving Pur1-Long and Pur1-Short were also seen to be inhibited by physiological levels of monovalent cations, particularly K + (data not shown). This is in agreement with previous studies that demonstrate purine motif triplex inhibition by monovalent cations (37) (38) (39) . Such inhibition is most likely caused by competing equilibria wherein the guanine-rich oligonucleotides become sequestered into guanine quartet aggregates (39) . Incorporation of 6-thioguanine into a limited number of positions of purine motif oligonucleotides has been shown to alleviate ion inhibition of triplexes (40, 41) and could potentially be used as a strategy to permit Pur1-Long and Pur1-Short to form triplexes under pseudo-physiological conditions.
In contrast with the purine motif oligonucleotides, pyrimidine motif oligonucleotides Pur2-Pyr and Pur2-Cross not only tolerated physiological ion concentrations, but were remarkably pH independent, being stable at pH 8.0. This result is notable in light of the requirement for cytidine protonation in the pyrimidine motif. The presence of 5-methylcytidine (Me 5 C) in Pur2-Pyr and Pur2-Cross is likely to be a large contributor to this pH independence. Previous studies have indicated that Me 5 C substitution allows certain oligonucleotide sequences to form triplexes at pH values >7, though the mechanism of stabilization is unclear (32) . However, the pH independence of Pur2-Pyr and Pur2-Cross is also sequence dependent, as triplexes involving other pyrimidine motif oligonucleotides containing Me 5 C are destabilized at neutral pH (data not shown). Perhaps thymidine-rich sequences lacking consecutive cytidines are most favorable for triplex stability >pH 7. Together with the results of previous studies (3) (4) (5) 8) , these data reinforce the view that conventional purine motif triplexes are stabilized by profoundly guanine-rich target strands, while conventional pyrimidine motif triplexes are stabilized by adenine-rich target strands punctuated with isolated guanine residues.
Another key result from these studies is the high affinity binding of alternate strand homopurine domains in the bcl-2 promoter by Pur2-Cross. In particular, Pur2-Cross recognizes the nine base homopurine domain of the Pur2 duplex to which oligonucleotide Pur2-Pur could not detectably bind. Moreover, the simultaneous recognition of both homopurine domains of the Pur2 duplex increases the affinity of Pur2-Cross almost 2-fold relative to the affinity of Pur2-Pyr under pseudo-physiological conditions. These results support previous studies in which alternate strand triple helix formation was shown to allow binding of adjacent homopurine domains of <10 bases when oligonucleotides could not bind either domain individually (27) . In addition, the present study provides evidence that alternate strand binding can increase the stability of a triple helix relative to binding a single domain of >10 bases. A previous study of alternate strand binding to domains >10 bases demonstrated a modest 1.4-fold increase in affinity relative to binding a single domain (31) .
DMS hypermethylation of guanines adjacent to duplex-triplex junctions is a common observation that presumably reflects perturbations in the duplex structure upon oligonucleotide binding (31, 42 ). An alternative hypothesis to explain the observed hypermethylation is that the terminal unstacked bases at triplex/duplex junctions creates a hydrophobic microenvironment that increases the local DMS concentration. Binding of Pur1-Short and Pur2-Pyr to target duplexes in this study promoted hypermethylation of the purine strand 3′ to the complex. In the case of Pur2-Pyr, hypermethylation of a pair of guanines was also seen on the opposite DNA strand at the same end of the complex. Interestingly, binding of Pur2-Cross caused an increase in hypermethylation at junction guanines on both strands of the target duplex. This suggests a strain or distortion in the duplex when Pur2-Cross traverses the major groove between alternate strands, thus causing the major groove to be more accessible to DMS. Such a distortion could reflect an energy expense associated with alternate strand binding (31) . Optimized oligonucleotide designs might reduce this apparent distortion.
Together, the results of this study indicate that a natural sequence in the human bcl-2 promoter can form a stable triplex with a synthetic oligonucleotide under pseudo-physiological conditions. Moreover, it is promising that this oligonucleotide can be modified to increase nuclease resistance without a significant decrease in binding affinity. Extension of these studies to intact cells will require attention to several obstacles: oligonucleotide delivery to the nucleus, availability of DNA target sites within chromatin structure, and the unknown effects of these triplex complexes on bcl-2 transcription. In vitro studies have shown that occlusion of transcription factor binding sites by triplexes can block transcription initiation (11, 43, 44) . Other studies indicate that direct overlap of protein and triplex binding sites may not be necessary for transcriptional inactivation by triplexes (2, 11, 13) . The latter results suggest that oligonucleotide binding may alter duplex DNA structure in some manner (bending, stiffening) so as to antagonize promoter function (11) . It is provocative to note that both Pur1 and Pur2 target sequences are located on or near consensus Sp1 binding sites within the P1 bcl-2 promoter. Further studies will be necessary to determine if triple-helical complexes identified in the present study will offer a feasible approach to transcriptional inhibition of the bcl-2 gene in living cells.
